My watch list
my.bionity.com  
Login  

100 Newest Publications in inflammopharmacology

rss

Anti-inflammatory and antioxidant potential of alginic acid isolated from the marine algae, Sargassum wightii on adjuvant-induced arthritic rats

26-11-2012 | C. H. Sarithakumari, G. L. Renju, G. Muraleedhara Kurup, Inflammopharmacology, 2012

The present study evaluated the anti-inflammatory and antioxidant potential of alginic acid isolated from brown algae Sargassum wightii in arthritic rats. Arthritis was induced in male Sprague–Dawley rats by intradermal injection of complete Freund’s adjuvant into the right hind paw, produce ...

more

Do anti-TNF-α drugs increase cancer risk in rheumatoid arthritis patients?

09-11-2012 | David A. Clark, Inflammopharmacology, 2012

Concern has been raised about an increased risk of lymphoma and skin cancers in patients with rheumatoid arthritis due to administration of anti-TNF-α drugs. Meta-analysis of observational data from registries as well as from randomized controlled trials has failed to show a significant ...

more

Frans P. Nijkamp, Michael J. Parnham (eds): Principles of immunopharmacology, 3rd revised and extended edition

05-11-2012 | K. D. Rainsford, Inflammopharmacology, 2012

Frans P. Nijkamp, Michael J. Parnham (eds): Principles of immunopharmacology, 3rd revised and extended edition Content Type Journal Article Category Book Review Pages 1-2 DOI 10.1007/s10787-012-0157-1 Authors K. D. Rainsford, Biomedical Research Centre, Sheffield Hallam ...

more

Gemfibrozil and its combination with metformin on pleiotropic effect on IL-10 and adiponectin and anti-atherogenic treatment in insulin resistant type 2 diabetes mellitus rats

31-10-2012 | Ashish Kumar Sharma, Sachin Kumar Raikwar, Muneem Kumar Kurmi, Bharthu Parthsarthi Srinivasan, Inflammopharmacology, 2012

Aim Gemfibrozil is a PPAR-α ligand that inhibits the progression of atherosclerosis in insulin resistance type 2 diabetes mellitus (IR type 2 DM). Gemfibrozil, poor anti-hyperglycemic combined with metformin, evaluated for MMP-9, IL-10 and adiponectin beyond glycemic control. Essential ...

more

Lyme disease: aetiopathogenesis, factors for disease development and control

30-10-2012 | I. R. Kean, K. L. Irvine, Inflammopharmacology, 2012

Lyme disease is caused by infection with several genospecies from the Borrelia burgdorferi sensu lato (s.l.) complex, and is transmitted by ixodid ticks. Human disease is an infrequent sequel to infection, which suggests that multiple factors underlie disease development. Several innate ...

more

The musculoskeletal abnormalities of the Simulaun Iceman (“ÖTZI”): clues to chronic pain and possible treatments

25-10-2012 | Walter F. Kean, Shannon Tocchio, Mary Kean, K. D. Rainsford, Inflammopharmacology, 2012

Background and Introduction In 1991, a deceased human male was found frozen in a glacier pool in the Italian Alps in north west Italy, and is now carefully preserved in the South Tyrol Museum of Archaeology, in Bolzano, Italy. The bodily tissues of the 5,300 year old male (colloquially ...

more

The pharmacological modulation of allergen-induced asthma

24-10-2012 | L. L. Ma, Paul M. O’Byrne, Inflammopharmacology, 2012

Aeroallergens are the most common triggers for the development of asthma. Recent birth cohort studies have identified viral infections occurring against a background of aeroallergen sensitization as a potent risk factor for initiation of asthma. Viral infection enhances immunopathogenic ...

more

Antihypernociceptive activity of anethole in experimental inflammatory pain

09-10-2012 | Alessandra M. V. Ritter, Talita P. Domiciano, Waldiceu A. Verri Jr, Ana Carla Zarpelon, Lorena G. da Silva, Carmem P ..., Inflammopharmacology, 2012

Anethole has been reported to have antioxidant, antibacterial, antifungal, antiinflammatory, and anesthetic properties. In the present study, we evaluated the effects of anethole in two pain models of inflammatory origin: acute inflammation induced by carrageenan and persistent inflammation ...

more

Systemic beneficial effects of Euphorbia besides its immunosuppressive effects

21-09-2012 | Shailendra Kapoor, Inflammopharmacology, 2012

Systemic beneficial effects of Euphorbia besides its immunosuppressive effects Content Type Journal Article Category Letter to the Editor Pages 1-2 DOI 10.1007/s10787-012-0151-7 Authors Shailendra Kapoor, Mechanicsville, VA, USA Journal Inflammopharmacology Online ...

more

Acute and chronic inflammation studies of Strobilanthes callosus leaves extract on rat model

16-09-2012 | Satish Kumar, Hitendra, Manisha Bhatia, Laxmi Naryan Garg, Sumeet Gupta, Inflammopharmacology, 2012

Aim To assess the protective efficacy of Strobilanthes callosus against the acute and chronic inflammation on rat model. Methods Inflammation was induced by carrageen and Freund’s complete adjuvant in plantar surface of the rats. The ethanol, chloroform and petroleum ether extracts in three ...

more

Page 1 From 10
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE